AWMSG publishes updated national prescribing indicators for 2013-2014
Source: All Wales Medicines Strategy Group (AWMSG)
Area: News
The All Wales Medicines Strategy Group (AWMSG) has endorsed revised National Prescribing Indicators for 2013-4, as set out in the document at the link below.
The indicators cover the following:
. Lipid-modifying drugs (items of low acquisition cost statins as a percentage of all statin, ezetimibe and simvastatin/ezetimibe combination prescribing)
. Hypnotics and anxiolytics (average daily quantity [ADQ] per 1,000 STAR-PUs)
. Dosulepin (defined daily dosage [DDD] per 1,000 PUs)
. Antidepressants (ADQ per 1,000 STAR-PUs)
. Opioid prescribing (morphine as a percentage of strong opioid prescribing)
. Antibiotics (items per 1,000 STAR-PUs; cephalosporins as a percentage of total antibacterial items; quinolones as a percentage of total antibacterial items; co-amoxiclav as a percentage of total antibacterial items)
. Insulin (long-acting insulin analogues as a percentage of total long- and ...
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news
More News: Cholesterol | Drugs & Pharmacology | Insulin | Mergers and Aquisitions | Morphine | Simvastatin | Statin Therapy | Vytorin | Zetia | Zocor